The global Unit Drug Dose Delivery System market is projected to reach US$ 199.9 million in 2029, increasing from US$ 22 million in 2022, with the CAGR of 36.1% during the period of 2023 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Unit Drug Dose Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Amcor Limited
Amcor
Wipak Group
Schott AG.
Nipro Corporation
Gerresheimer
West Pharmaceutical Services
R-Pharm Germany GmbH
Agrado S.A
Constantia Flexibles Group
Stevanato Group
Klockner Pentaplast Group
Catalent, Inc.
Huhtamaki Oyj.
Omnicell, Inc.
Piramal Glass Limited
O.Berk Company, LLC
SGD Pharma.
Segment by Type
Blister Packaging
Pre-fillable Syringes & Catridges
Vials & Ampoules
Others (Pouches, Sticks)
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Unit Drug Dose Delivery System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Unit Drug Dose Delivery System Market Overview
1.1 Product Overview and Scope of Unit Drug Dose Delivery System
1.2 Unit Drug Dose Delivery System Segment by Type
1.2.1 Global Unit Drug Dose Delivery System Market Value Comparison by Type (2023-2029)
1.2.2 Blister Packaging
1.2.3 Pre-fillable Syringes & Catridges
1.2.4 Vials & Ampoules
1.2.5 Others (Pouches, Sticks)
1.3 Unit Drug Dose Delivery System Segment by Application
1.3.1 Global Unit Drug Dose Delivery System Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Unit Drug Dose Delivery System Market Size Estimates and Forecasts
1.4.1 Global Unit Drug Dose Delivery System Revenue 2018-2029
1.4.2 Global Unit Drug Dose Delivery System Sales 2018-2029
1.4.3 Global Unit Drug Dose Delivery System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Unit Drug Dose Delivery System Market Competition by Manufacturers
2.1 Global Unit Drug Dose Delivery System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Unit Drug Dose Delivery System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Unit Drug Dose Delivery System Average Price by Manufacturers (2018-2023)
2.4 Global Unit Drug Dose Delivery System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Unit Drug Dose Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Unit Drug Dose Delivery System, Product Type & Application
2.7 Unit Drug Dose Delivery System Market Competitive Situation and Trends
2.7.1 Unit Drug Dose Delivery System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Unit Drug Dose Delivery System Players Market Share by Revenue
2.7.3 Global Unit Drug Dose Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Unit Drug Dose Delivery System Retrospective Market Scenario by Region
3.1 Global Unit Drug Dose Delivery System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Unit Drug Dose Delivery System Global Unit Drug Dose Delivery System Sales by Region: 2018-2029
3.2.1 Global Unit Drug Dose Delivery System Sales by Region: 2018-2023
3.2.2 Global Unit Drug Dose Delivery System Sales by Region: 2024-2029
3.3 Global Unit Drug Dose Delivery System Global Unit Drug Dose Delivery System Revenue by Region: 2018-2029
3.3.1 Global Unit Drug Dose Delivery System Revenue by Region: 2018-2023
3.3.2 Global Unit Drug Dose Delivery System Revenue by Region: 2024-2029
3.4 North America Unit Drug Dose Delivery System Market Facts & Figures by Country
3.4.1 North America Unit Drug Dose Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Unit Drug Dose Delivery System Sales by Country (2018-2029)
3.4.3 North America Unit Drug Dose Delivery System Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Unit Drug Dose Delivery System Market Facts & Figures by Country
3.5.1 Europe Unit Drug Dose Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Unit Drug Dose Delivery System Sales by Country (2018-2029)
3.5.3 Europe Unit Drug Dose Delivery System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Unit Drug Dose Delivery System Market Facts & Figures by Country
3.6.1 Asia Pacific Unit Drug Dose Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Unit Drug Dose Delivery System Sales by Country (2018-2029)
3.6.3 Asia Pacific Unit Drug Dose Delivery System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Unit Drug Dose Delivery System Market Facts & Figures by Country
3.7.1 Latin America Unit Drug Dose Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Unit Drug Dose Delivery System Sales by Country (2018-2029)
3.7.3 Latin America Unit Drug Dose Delivery System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Unit Drug Dose Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Unit Drug Dose Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Unit Drug Dose Delivery System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Unit Drug Dose Delivery System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Unit Drug Dose Delivery System Sales by Type (2018-2029)
4.1.1 Global Unit Drug Dose Delivery System Sales by Type (2018-2023)
4.1.2 Global Unit Drug Dose Delivery System Sales by Type (2024-2029)
4.1.3 Global Unit Drug Dose Delivery System Sales Market Share by Type (2018-2029)
4.2 Global Unit Drug Dose Delivery System Revenue by Type (2018-2029)
4.2.1 Global Unit Drug Dose Delivery System Revenue by Type (2018-2023)
4.2.2 Global Unit Drug Dose Delivery System Revenue by Type (2024-2029)
4.2.3 Global Unit Drug Dose Delivery System Revenue Market Share by Type (2018-2029)
4.3 Global Unit Drug Dose Delivery System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Unit Drug Dose Delivery System Sales by Application (2018-2029)
5.1.1 Global Unit Drug Dose Delivery System Sales by Application (2018-2023)
5.1.2 Global Unit Drug Dose Delivery System Sales by Application (2024-2029)
5.1.3 Global Unit Drug Dose Delivery System Sales Market Share by Application (2018-2029)
5.2 Global Unit Drug Dose Delivery System Revenue by Application (2018-2029)
5.2.1 Global Unit Drug Dose Delivery System Revenue by Application (2018-2023)
5.2.2 Global Unit Drug Dose Delivery System Revenue by Application (2024-2029)
5.2.3 Global Unit Drug Dose Delivery System Revenue Market Share by Application (2018-2029)
5.3 Global Unit Drug Dose Delivery System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Amcor Limited
6.1.1 Amcor Limited Corporation Information
6.1.2 Amcor Limited Description and Business Overview
6.1.3 Amcor Limited Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amcor Limited Unit Drug Dose Delivery System Product Portfolio
6.1.5 Amcor Limited Recent Developments/Updates
6.2 Amcor
6.2.1 Amcor Corporation Information
6.2.2 Amcor Description and Business Overview
6.2.3 Amcor Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amcor Unit Drug Dose Delivery System Product Portfolio
6.2.5 Amcor Recent Developments/Updates
6.3 Wipak Group
6.3.1 Wipak Group Corporation Information
6.3.2 Wipak Group Description and Business Overview
6.3.3 Wipak Group Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Wipak Group Unit Drug Dose Delivery System Product Portfolio
6.3.5 Wipak Group Recent Developments/Updates
6.4 Schott AG.
6.4.1 Schott AG. Corporation Information
6.4.2 Schott AG. Description and Business Overview
6.4.3 Schott AG. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Schott AG. Unit Drug Dose Delivery System Product Portfolio
6.4.5 Schott AG. Recent Developments/Updates
6.5 Nipro Corporation
6.5.1 Nipro Corporation Corporation Information
6.5.2 Nipro Corporation Description and Business Overview
6.5.3 Nipro Corporation Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nipro Corporation Unit Drug Dose Delivery System Product Portfolio
6.5.5 Nipro Corporation Recent Developments/Updates
6.6 Gerresheimer
6.6.1 Gerresheimer Corporation Information
6.6.2 Gerresheimer Description and Business Overview
6.6.3 Gerresheimer Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Gerresheimer Unit Drug Dose Delivery System Product Portfolio
6.6.5 Gerresheimer Recent Developments/Updates
6.7 West Pharmaceutical Services
6.6.1 West Pharmaceutical Services Corporation Information
6.6.2 West Pharmaceutical Services Description and Business Overview
6.6.3 West Pharmaceutical Services Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 West Pharmaceutical Services Unit Drug Dose Delivery System Product Portfolio
6.7.5 West Pharmaceutical Services Recent Developments/Updates
6.8 R-Pharm Germany GmbH
6.8.1 R-Pharm Germany GmbH Corporation Information
6.8.2 R-Pharm Germany GmbH Description and Business Overview
6.8.3 R-Pharm Germany GmbH Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 R-Pharm Germany GmbH Unit Drug Dose Delivery System Product Portfolio
6.8.5 R-Pharm Germany GmbH Recent Developments/Updates
6.9 Agrado S.A
6.9.1 Agrado S.A Corporation Information
6.9.2 Agrado S.A Description and Business Overview
6.9.3 Agrado S.A Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Agrado S.A Unit Drug Dose Delivery System Product Portfolio
6.9.5 Agrado S.A Recent Developments/Updates
6.10 Constantia Flexibles Group
6.10.1 Constantia Flexibles Group Corporation Information
6.10.2 Constantia Flexibles Group Description and Business Overview
6.10.3 Constantia Flexibles Group Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Constantia Flexibles Group Unit Drug Dose Delivery System Product Portfolio
6.10.5 Constantia Flexibles Group Recent Developments/Updates
6.11 Stevanato Group
6.11.1 Stevanato Group Corporation Information
6.11.2 Stevanato Group Unit Drug Dose Delivery System Description and Business Overview
6.11.3 Stevanato Group Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Stevanato Group Unit Drug Dose Delivery System Product Portfolio
6.11.5 Stevanato Group Recent Developments/Updates
6.12 Klockner Pentaplast Group
6.12.1 Klockner Pentaplast Group Corporation Information
6.12.2 Klockner Pentaplast Group Unit Drug Dose Delivery System Description and Business Overview
6.12.3 Klockner Pentaplast Group Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Klockner Pentaplast Group Unit Drug Dose Delivery System Product Portfolio
6.12.5 Klockner Pentaplast Group Recent Developments/Updates
6.13 Catalent, Inc.
6.13.1 Catalent, Inc. Corporation Information
6.13.2 Catalent, Inc. Unit Drug Dose Delivery System Description and Business Overview
6.13.3 Catalent, Inc. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Catalent, Inc. Unit Drug Dose Delivery System Product Portfolio
6.13.5 Catalent, Inc. Recent Developments/Updates
6.14 Huhtamaki Oyj.
6.14.1 Huhtamaki Oyj. Corporation Information
6.14.2 Huhtamaki Oyj. Unit Drug Dose Delivery System Description and Business Overview
6.14.3 Huhtamaki Oyj. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Huhtamaki Oyj. Unit Drug Dose Delivery System Product Portfolio
6.14.5 Huhtamaki Oyj. Recent Developments/Updates
6.15 Omnicell, Inc.
6.15.1 Omnicell, Inc. Corporation Information
6.15.2 Omnicell, Inc. Unit Drug Dose Delivery System Description and Business Overview
6.15.3 Omnicell, Inc. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Omnicell, Inc. Unit Drug Dose Delivery System Product Portfolio
6.15.5 Omnicell, Inc. Recent Developments/Updates
6.16 Piramal Glass Limited
6.16.1 Piramal Glass Limited Corporation Information
6.16.2 Piramal Glass Limited Unit Drug Dose Delivery System Description and Business Overview
6.16.3 Piramal Glass Limited Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Piramal Glass Limited Unit Drug Dose Delivery System Product Portfolio
6.16.5 Piramal Glass Limited Recent Developments/Updates
6.17 O.Berk Company, LLC
6.17.1 O.Berk Company, LLC Corporation Information
6.17.2 O.Berk Company, LLC Unit Drug Dose Delivery System Description and Business Overview
6.17.3 O.Berk Company, LLC Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.17.4 O.Berk Company, LLC Unit Drug Dose Delivery System Product Portfolio
6.17.5 O.Berk Company, LLC Recent Developments/Updates
6.18 SGD Pharma.
6.18.1 SGD Pharma. Corporation Information
6.18.2 SGD Pharma. Unit Drug Dose Delivery System Description and Business Overview
6.18.3 SGD Pharma. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.18.4 SGD Pharma. Unit Drug Dose Delivery System Product Portfolio
6.18.5 SGD Pharma. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Unit Drug Dose Delivery System Industry Chain Analysis
7.2 Unit Drug Dose Delivery System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Unit Drug Dose Delivery System Production Mode & Process
7.4 Unit Drug Dose Delivery System Sales and Marketing
7.4.1 Unit Drug Dose Delivery System Sales Channels
7.4.2 Unit Drug Dose Delivery System Distributors
7.5 Unit Drug Dose Delivery System Customers
8 Unit Drug Dose Delivery System Market Dynamics
8.1 Unit Drug Dose Delivery System Industry Trends
8.2 Unit Drug Dose Delivery System Market Drivers
8.3 Unit Drug Dose Delivery System Market Challenges
8.4 Unit Drug Dose Delivery System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Amcor Limited
Amcor
Wipak Group
Schott AG.
Nipro Corporation
Gerresheimer
West Pharmaceutical Services
R-Pharm Germany GmbH
Agrado S.A
Constantia Flexibles Group
Stevanato Group
Klockner Pentaplast Group
Catalent, Inc.
Huhtamaki Oyj.
Omnicell, Inc.
Piramal Glass Limited
O.Berk Company, LLC
SGD Pharma.
Ěý
Ěý
*If Applicable.